153 articles, page 13 of 13
Newest first
Semaglutide is a medication that has transformed the management of type 2 diabetes and obesity by helping to control blood sugar and reduce body weight.
By Harbor Health Team
Semaglutide has emerged as a breakthrough medication for chronic weight management and type 2 diabetes.
By Harbor Health Team
GLP-1 receptor agonists have emerged as a groundbreaking class of treatments for type 2 diabetes and obesity.
By Harbor Health Team
Ozempic and Wegovy are two brand-name medications that share the same active ingredient, yet they serve different primary purposes.
By Harbor Health Team
Tracking progress on weight loss medication can be challenging: you’re excited about results but worry about every fluctuation.
By Harbor Health Team
Semaglutide has emerged as a powerful tool for weight management, helping people shed significant pounds by curbing appetite and improving blood sugar control.
By Harbor Health Team
Ozempic (semaglutide) has rapidly become one of the most talked-about medications in health care.
By Harbor Health Team
The rise of GLP-1 weight loss treatments has revolutionized obesity care, offering a new level of effectiveness through once-weekly injections.
By Harbor Health Team
Tirzepatide works, with the 21% average weight loss seen in the SURMOUNT-1 trial, is unlike anything obesity medicine has produced before.
By Harbor Health Team
